Impact of Early MPO-ANCA Positivity on Unique Clinical Features in Korean Patients with EGPA: A Single-Centre Cohort Study.
- Published in:
- Medicina (1010660X), 2025, v. 61, n. 6, p. 1088, doi. 10.3390/medicina61061088
- By:
- Publication type:
- Article
Works by Ha, Jang Woo
Results: 28
1
2
Clinical Significance of Peripheral Arterial Disease Evaluation in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
- Published in:
- Medicina (1010660X), 2025, v. 61, n. 6, p. 1074, doi. 10.3390/medicina61061074
- By:
- Publication type:
- Article
3
BVAS version 3 and BVAS/GPA: standing on the same line?
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 11, p. 3429, doi. 10.1007/s10067-022-06267-z
- By:
- Publication type:
- Article
4
Validation of the 2022 ACR/EULAR classification criteria for giant cell arteritis in Korean patients with giant cell arteritis.
- Published in:
- Modern Rheumatology, 2025, v. 35, n. 3, p. 524, doi. 10.1093/mr/roae110
- By:
- Publication type:
- Article
5
Application of the 2022 ACR/EULAR criteria for Takayasu arteritis to previously diagnosed patients based on the 1990 ACR criteria.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 5, p. 1006, doi. 10.1093/mr/road105
- By:
- Publication type:
- Article
6
Serum glutathione peroxidase-3 concentration at diagnosis as a biomarker for assessing disease activity and damage of antineutrophil cytoplasmic antibody-associated vasculitis at diagnosis.
- Published in:
- Frontiers in Molecular Biosciences, 2025, p. 1, doi. 10.3389/fmolb.2025.1549454
- By:
- Publication type:
- Article
7
Clinical Utility of Serum sCD200/sCD200R Ratios in Predicting Current Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 8, p. 2720, doi. 10.3390/jcm14082720
- By:
- Publication type:
- Article
8
Remnant Cholesterol Levels at Diagnosis May Predict Acute Coronary Syndrome Occurrence During Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 7, p. 2260, doi. 10.3390/jcm14072260
- By:
- Publication type:
- Article
9
Circulating GDF15 May Estimate Vasculitis Activity and Predict Poor Outcomes During the Disease Course of ANCA-Associated Vasculitis.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 6, p. 1876, doi. 10.3390/jcm14061876
- By:
- Publication type:
- Article
10
Clinical Significance of Overlap Syndrome of Histologically Confirmed Lupus Nephritis with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 19, p. 5831, doi. 10.3390/jcm13195831
- By:
- Publication type:
- Article
11
Overlap Syndrome Consisting of Polymyositis/Dermatomyositis and ANCA-Associated Vasculitis According to the 2022 ACR/EULAR Criteria for Vasculitis: A Korean Single-Centre Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 21, p. 6748, doi. 10.3390/jcm12216748
- By:
- Publication type:
- Article
12
Total Globulin Fraction at Diagnosis Could Forecast All-Cause Mortality during the Disease Course in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 12, p. 4170, doi. 10.3390/jcm12124170
- By:
- Publication type:
- Article
13
Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single-Centre Observational Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
14
Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander?
- Published in:
- Rheumatology, 2022, v. 61, n. 4, p. 1366, doi. 10.1093/rheumatology/keab595
- By:
- Publication type:
- Article
15
Circulating cold-inducible RNA-binding protein levels in microscopic polyangiitis and granulomatosis with polyangiitis: Correlation with disease activity.
- Published in:
- Zeitschrift für Rheumatologie, 2024, v. 83, p. 230, doi. 10.1007/s00393-023-01320-x
- By:
- Publication type:
- Article
16
A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-23180-2
- By:
- Publication type:
- Article
17
Prevalence and persistence of autoantibodies in COVID-19 patients.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 312
- By:
- Publication type:
- Article
18
Serum Glial Fibrillary Acidic Protein Can Predict Cross-Sectional Vasculitis Activity by Reflecting Renal Involvement in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
- Published in:
- Medicina (1010660X), 2024, v. 60, n. 10, p. 1639, doi. 10.3390/medicina60101639
- By:
- Publication type:
- Article
19
Serum syndecan1 has the potential to reflect activity at diagnosis and predict death during follow-up in patients with ANCA-associated vasculitis.
- Published in:
- Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03393-8
- By:
- Publication type:
- Article
20
Risk of Gout Among Patients With Tuberculosis: A Nationwide Cohort Study in South Korea.
- Published in:
- International Journal of Rheumatic Diseases, 2025, v. 28, n. 3, p. 1, doi. 10.1111/1756-185X.70197
- By:
- Publication type:
- Article
21
Serum Soluble Receptors for Advanced Glycation End-Products May Predict Mortality in Microscopic Polyangiitis and Granulomatosis with Polyangiitis.
- Published in:
- Yonsei Medical Journal, 2024, v. 65, n. 11, p. 651, doi. 10.3349/ymj.2023.0466
- By:
- Publication type:
- Article
22
Vasculitis Activity-Predicting Ability of IL-12 Family Cytokines in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis.
- Published in:
- Yonsei Medical Journal, 2023, v. 64, n. 10, p. 604, doi. 10.3349/ymj.2023.0226
- By:
- Publication type:
- Article
23
Overlap Syndrome of Primary Sjögren Syndrome with Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Based on the American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) Criteria.
- Published in:
- Diagnostics (2075-4418), 2025, v. 15, n. 9, p. 1099, doi. 10.3390/diagnostics15091099
- By:
- Publication type:
- Article
24
Clinical implications of peripheral eosinophil count at diagnosis in patients newly diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis.
- Published in:
- Arthritis Research & Therapy, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13075-023-03233-1
- By:
- Publication type:
- Article
25
Prevalence, clinical significance, and persistence of autoantibodies in COVID-19.
- Published in:
- Virology Journal, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12985-023-02191-z
- By:
- Publication type:
- Article
26
Prevalence, clinical significance, and persistence of autoantibodies in COVID-19.
- Published in:
- Virology Journal, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12985-023-02191-z
- By:
- Publication type:
- Article
27
Predictive potential of albumin-alkaline phosphatase ratio for cerebrovascular accident in patients with antineutrophil cytoplasmic antibody–associated vasculitis.
- Published in:
- Annals of Clinical Biochemistry, 2023, v. 60, n. 3, p. 184, doi. 10.1177/00045632231154752
- By:
- Publication type:
- Article
28
Serum Biomarkers of Pulmonary Damage and Risk for Progression of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
- Published in:
- Journal of Rheumatology, 2025, v. 52, n. 4, p. 323, doi. 10.3899/jrheum.2024-0713
- By:
- Publication type:
- Article